WU
48
-4
JNJ
56
-3
EQIX
45
3
AFL
49
-3
CMI
49
12
MNST
61
-4
PH
63
3
VIX
80
-6
HRB
37
-12
VNO
49
7
DVN
35
14
ADBE
45
10
JWN
53
-2
AES
44
-3
CI
63
-5
CA
10
-6
RF
44
3
RL
59
4
NWL
35
3
DRI
66
3
WU
48
-4
JNJ
56
-3
EQIX
45
3
AFL
49
-3
CMI
49
12
MNST
61
-4
PH
63
3
VIX
80
-6
HRB
37
-12
VNO
49
7
DVN
35
14
ADBE
45
10
JWN
53
-2
AES
44
-3
CI
63
-5
CA
10
-6
RF
44
3
RL
59
4
NWL
35
3
DRI
66
3
Financhill
Back

Vermilion Energy Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

VET
Vermilion Energy

Last Price:
$7.67
Seasonality Move:
-3.78%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.36
Seasonality Move:
6.73%
Sell
29
Vermilion Energy (VET) is a Sell

Is Vermilion Energy a Buy, Sell or Hold?

  • The current Vermilion Energy [VET] share price is $8.15. The Score for VET is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • VET is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VET Stock Price Chart

What is Vermilion Energy's stock price today?

  • The Vermilion Energy share price today is $8.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VET is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

VET Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 43.96 Sell
Chaikin Money Flow: 1429560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.98 - 9.32) Sell
Bollinger Bands (100): (8.77 - 10.17) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

VET Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.8 Buy
20-day SMA: 8.54 Sell
50-day SMA: 9.21 Sell
200-day SMA: 10.02 Sell
8-day EMA: 7.93 Buy
20-day EMA: 8.37 Sell
50-day EMA: 8.95 Sell
200-day EMA: 10.01 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Vermilion Energy Earnings Growth & VET Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.88 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Vermilion Energy Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):